ARTICLE | Clinical News
Delenex preclinical data
July 13, 2015 7:00 AM UTC
In a mouse xenograft model of glioma, DLX1008 significantly improved survival and inhibited tumor growth vs. controls. Next year, Delenex plans to start Phase I/II testing of the monovalent antibody f...